Labshake search
Citations for Tocris :
651 - 700 of 953 citations for 3 hydroxy 20 oxopregn 5 en 21 yl acetate since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... mGluR2/3s were blocked using LY 341495 (1-5 µM, Tocris). AMPARs were blocked using NBQX (5 µM ...
-
bioRxiv - Cell Biology 2024Quote: ... D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50 µM, Tocris), 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX 20 µM ...
-
bioRxiv - Genetics 2024Quote: ... D-2-amino-5-phosphonovalerate (D-AP5; 100 µM, Tocris 0106), bicuculline (20 µM ...
-
bioRxiv - Neuroscience 2021Quote: Varenicline or 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h] [3]benzazepine tartrate (Tocris, UK) was dissolved in sterile 0.9% physiological saline for a final dose of 1 mg/kg free base ...
-
bioRxiv - Neuroscience 2020Quote: ... medium was exchanged every 3-4 days with RGC induction media containing: DAPT (3uM, Tocris), 10μM Rock inhibitor (Y27632) ...
-
bioRxiv - Neuroscience 2021Quote: ... some slices were incubated at 37°C with 3 µM puromycin (Tocris #40-895-0) at 65-75 minutes post-slicing ...
-
bioRxiv - Neuroscience 2022Quote: ... with the addition of either 3 μM or 10 mM GABA (Tocris; Cat. No. 0344). Sylgard 184 (Dow Corning ...
-
bioRxiv - Neuroscience 2021Quote: AM251 pharmacology: in experiments using the CB1 antagonist AM251 (3 µM) (Tocris and AdooQ biosciences), the drug (diluted in DMSO ...
-
bioRxiv - Neuroscience 2020Quote: ... with either 3 mg/kg clozapine N-oxide (CNO; Tocris, Catalog: 4936, Lot: 13D/233085) in 0.5% DMSO and saline ...
-
bioRxiv - Neuroscience 2022Quote: ... mEPSCs were recorded in the presence of 3 μM AMPA receptor antagonist NBQX (Tocris Bioscience) in standard external solution.
-
bioRxiv - Cell Biology 2023Quote: ... the CDBM medium was supplemented with 0.6 U/ml heparin and 3 mM IWP2 (Tocris) for another 3-day incubation with medium refreshed daily ...
-
bioRxiv - Molecular Biology 2024Quote: ... AML12 cells at 70% confluency were treated with 3 μM CHIR99021 (cat. no. 4423; Tocris) for 48h ...
-
bioRxiv - Neuroscience 2024Quote: ... each animal underwent 3 consecutive trials before and after treatment with prazosin (7.5mg/kg, Tocris Biosciences ...
-
bioRxiv - Cell Biology 2024Quote: ... 10 mM 3-methyladenine (3MA, diluted directly into cell culture medium at 10mM; Tocris, 3977), 2.5 µM brefeldin A (diluted from 25mM stock prepared in DMSO ...
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247; 5 μM SR-95531, Tocris, 1262; 1 μM CGP-55845, Tocris, 1248) were included in the recording solutions.
-
bioRxiv - Cell Biology 2020Quote: ... The following pharmacological inhibitors were used in this study: ML-9 (Tocris, 0431/10, 20 μM), Y27632 (Abmole ...
-
bioRxiv - Neuroscience 2020Quote: ... In all cases when tested sIPSCs were fully blocked by 20 μM SR-95531 (Tocris Bioscience). Spontaneous EPSCs (sEPSCs ...
-
bioRxiv - Neuroscience 2020Quote: ... The VCP inhibitor cultures were treated with either ML240 (20 μM, TOCRIS, Bio-Techne GmbH, 5153) or Eeyarestatin I (10 μM ...
-
bioRxiv - Neuroscience 2024Quote: AMPA/kainate glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 20 μM, Tocris Bioscience) and NMDA glutamate receptor antagonist (RS)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid ((RS)-CPP ...
-
bioRxiv - Developmental Biology 2021Quote: ... NMP differentiation medium was supplemented with and 5 μM Y-27632 (Tocris).
-
bioRxiv - Cell Biology 2021Quote: Cells were treated with the actin inhibitor Cytochalasin-D (5 μM, Tocris), the Ezrin Inhibitor NSC668394 (50 μM ...
-
bioRxiv - Developmental Biology 2022Quote: ... cells were refreshed with BPEL supplemented with 5 μM XAV939 (Tocris Bioscience) and 50 ng/ml VEGF (R&D Systems) ...
-
bioRxiv - Physiology 2021Quote: ... SN-401 (DCPIB, 5 mg/kg of body weight/day, Tocris, D1540), SN-403 ...
-
bioRxiv - Developmental Biology 2021Quote: ... for 48 h followed by treatment with IWP2 (5 μM, Tocris, #3533) for an additional 48 h ...
-
bioRxiv - Cell Biology 2020Quote: ... 5 mg/kg BW for 2,3-bis(4-Hydroxyphenyl)-propionitrile (DPN, Tocris), or vehicle ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5, Tocris Bioscience) were added to the bath to block glutamatergic currents ...
-
bioRxiv - Cell Biology 2020Quote: ... media was changed to R/B-supplemented with 5 uM IWP2 (Tocris) for 48 hours ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Neuroscience 2022Quote: ... D-2-Amino-5-phosphonopentanoic acid (D-AP5, 25 μM; Tocris #0106). These were stored as stock aliquots and diluted in fresh aCSF to their final concentration the day of recording ...
-
bioRxiv - Bioengineering 2022Quote: ... and Nodal/Activin inhibitor (SB431542, Tocris, 1614, 5 µM, days 1-10). On day 2 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... [d-Ala2,MePhe4,Gly (ol)5]enkephalin (DAMGO) was purchased from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Neuroscience 2023Quote: ... was used to block GluN2A and ifenprodil (5 µM, Tocris, Cat#0545) was used to block GluN2B ...
-
bioRxiv - Neuroscience 2023Quote: ... The selective 5-HT2C receptor antagonist RS102221 (Tocris Bioscience, #1050, Minneapolis, MN) was dissolved in a 50% aCSF and 50% sterile saline solution and infused bilaterally into the aBNST at a dose of 0.5 µg per side [14][14] ...
-
bioRxiv - Systems Biology 2023Quote: ... 10 μM Forskolin (Fisher, BP2520-5) and 100 μM IBMX (Tocris, 2845). Cells were maintained in incubators at 37°C ...
-
bioRxiv - Bioengineering 2023Quote: ... and TGF-Beta inhibitor (SB431542, Tocris # 1614, 5 μM, days 0-7). Media was changed on days 3 and 6 and then every 2-3 days until day 7 ...
-
bioRxiv - Genomics 2023Quote: ... 2,3-Bis(4-hydroxyphenyl)propionitrile (DPN, 5 mg/kg body weight, Tocris) and 4-(2-(3,5-dimethylisoxazol-4-yl)-1H-indol-3-yl)phenol (DIP ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: A CC-chemokine receptor 5 (CCR5) antagonist (maraviroc; Tocris Biosciences, Bristol, UK) was dissolved in dimethyl sulfoxide and diluted with sterile PBS for further use ...
-
bioRxiv - Cell Biology 2023Quote: ... Mitotic exit was induced by adding flavopiridol (Tocris Bioscience, 131740-09-5) to a final concentration of 20 µM ...
-
bioRxiv - Neuroscience 2024Quote: ... and D-2-amino-5-posphonopentanoic acid (APV, 100 μM; Tocris, US) at a holding potential−70 mV (n = 12).
-
bioRxiv - Neuroscience 2024Quote: ... and 5 µM TGF-Beta Inhibitor (SB431542, Tocris # 1614, Days 0-18). Media changes occurred on Days 3 ...
-
bioRxiv - Neuroscience 2024Quote: ... The 5-HT2C receptor antagonist SB242084 (1 μM in 0.5 μL, Tocris) was dissolved in DMSO and diluted in saline (0.01% v/v DMSO) ...
-
bioRxiv - Neuroscience 2024Quote: ... and 50 µM 2-amino-5-phosphonopentanoic acid (D-AP5, Tocris Bioscience) were present in the extracellular solutions to isolate spontaneous IPSCs ...
-
bioRxiv - Neuroscience 2024Quote: ... EdU (10 μM) with or without the acetylcholine (0.5-5 μM, Tocris) was added and incubated for a further 24h ...
-
bioRxiv - Cell Biology 2024Quote: ... either with or without the additional supplementation of 5 nM T3 (Tocris), 100 nM sodium selenite (NaSe ...
-
bioRxiv - Developmental Biology 2020Quote: ... short-term serum-free culture was carried out in N2B27 supplemented with 3 μM CHIR99201 (Tocris), 1 μg/ml of Heparin (Sigma ...
-
bioRxiv - Developmental Biology 2020Quote: ... mTeSR Plus was replaced with the N2B27 basal medium supplemented with 3 μM CHIR99021 (Tocris Bioscience) and 40 ng/ml basic fibroblast growth factor bFGF/FGF2 (R&D Systems) ...
-
bioRxiv - Neuroscience 2020Quote: ... each disk with neurons was transferred into the physiological saline solution containing NBQX (3 μM, Tocris) and bicuculine (30 μM ...
-
Safety and efficacy of C9ORF72-repeat RNA nuclear export inhibition in amyotrophic lateral sclerosisbioRxiv - Systems Biology 2021Quote: ... supplemented with SMAD inhibitors (DMH-1 2 µM; SB431542-10 µM and CHIR99021 3 µM [ [Tocris]). The medium was changed every day for 6 days ...
-
bioRxiv - Bioengineering 2021Quote: ... Plates were centrifuged at 100xg for 3 minutes in E8 medium containing 10 μM Y27632 (Tocris). The following day ...
-
bioRxiv - Neuroscience 2020Quote: NNC-711 (1,2,5,6-Tetrahydro-1-[2-[[(diphenylmethylene)amino]oxy]ethyl]-3-pyridinecarboxylic acid hydrochloride) from Tocris